| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.011 | 1 |